Search scope:
排序: Display mode:
Type 2 diabetic patients with non-alcoholic fatty liver disease exhibit significant haemorheological
Hui Dong, Fu’er Lu, Nan Wang, Xin Zou, Jingjing Rao
Frontiers of Medicine 2011, Volume 5, Issue 3, Pages 288-293 doi: 10.1007/s11684-011-0127-9
Keywords: diabetes mellitus type 2 haemorheology non-alcoholic fatty liver disease
miRNAs in non-alcoholic fatty liver disease
Zhen He,Cheng Hu,Weiping Jia
Frontiers of Medicine 2016, Volume 10, Issue 4, Pages 389-396 doi: 10.1007/s11684-016-0468-5
Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver cirrhosis and hepatocellular carcinoma
Keywords: nonalcoholic fatty liver disease nonalcoholic steatohepatitis hepatocellular carcinoma miRNA
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 745-759 doi: 10.1007/s11684-021-0880-3
Keywords: insulin resistance non-alcoholic fatty liver disease Chinese herbal medicine randomized controlled
Ruiting Han, Junli Ma, Houkai Li
Frontiers of Medicine 2018, Volume 12, Issue 6, Pages 645-657 doi: 10.1007/s11684-018-0645-9
Keywords: gut microbiota NAFLD obesity insulin resistance bile acids probiotic
Shasha Zhu, Huimin Zhang, Li Bai
Frontiers of Medicine 2018, Volume 12, Issue 3, Pages 249-261 doi: 10.1007/s11684-018-0622-3
Keywords: natural killer T cells hepatitis B virus and hepatitis C virus infection autoimmune liver diseases alcoholic
Xuefu Wang, Zhigang Tian
Frontiers of Medicine 2018, Volume 12, Issue 3, Pages 262-268 doi: 10.1007/s11684-017-0584-x
Keywords: γδT cells liver infection non-alcoholic fatty liver disease autoimmune hepatitis liver fibrosis and cirrhosis
Mingfei Yao, Lingling Qv, Yanmeng Lu, Baohong Wang, Björn Berglund, Lanjuan Li
Engineering 2021, Volume 7, Issue 5, Pages 679-686 doi: 10.1016/j.eng.2020.01.017
Non-alcoholic fatty liver disease (NAFLD), which has a global prevalence of 20%–33%, has become
Keywords: Non-alcoholic fatty liver disease (NAFLD) Gut microbiota Probiotics Next-generation probiotics (NGPs
Xianyi Zeng, Xiang Zhang, Hao Su, Hongyan Gou, Harry Cheuk-Hay Lau, Xiaoxu Hu, Ziheng Huang, Yan Li, Jun Yu
Engineering 2024, Volume 35, Issue 4, Pages 257-269 doi: 10.1016/j.eng.2022.10.010
Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease without
Keywords: Pien Tze Huang Non-alcoholic steatohepatitis Gut barrier function Gut microbiota
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 714-722 doi: 10.1007/s11684-021-0888-8
Keywords: metabolic dysfunction-associated fatty liver disease non-alcoholic fatty liver disease fibrosis score
Title Author Date Type Operation
Type 2 diabetic patients with non-alcoholic fatty liver disease exhibit significant haemorheological
Hui Dong, Fu’er Lu, Nan Wang, Xin Zou, Jingjing Rao
Journal Article
Decoction, a Chinese herbal formula, improves insulin resistance in overweight/obese subjects with non-alcoholic
Journal Article
Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota
Ruiting Han, Junli Ma, Houkai Li
Journal Article
An Update on the Efficacy and Functionality of Probiotics for the Treatment of Non-Alcoholic Fatty Liver
Mingfei Yao, Lingling Qv, Yanmeng Lu, Baohong Wang, Björn Berglund, Lanjuan Li
Journal Article
Pien Tze Huang Protects Against Non-Alcoholic Steatohepatitis by Modulating the Gut Microbiota and Metabolites
Xianyi Zeng, Xiang Zhang, Hao Su, Hongyan Gou, Harry Cheuk-Hay Lau, Xiaoxu Hu, Ziheng Huang, Yan Li, Jun Yu
Journal Article